Comparison of chemotherapy response and adverse effects of double ‐platinum plus egfr‐tki versus double‐platinum alone on patients with nsclc who had disease progression following egfr‐tki treatment
Source: Respirology - Category: Respiratory Medicine Tags: APSR Poster Abstracts Source Type: research
More News: Chemotherapy | Non-Small Cell Lung Cancer